Antony Mattessich
Directeur/Bestuurslid bij AURA BIOSCIENCES, INC.
Vermogen: 1 M $ op 31-05-2024
Actieve functies van Antony Mattessich
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| AURA BIOSCIENCES, INC. | Directeur/Bestuurslid | 29-09-2021 | - |
| Independent Dir/Board Member | 29-09-2021 | - |
Loopbaan van Antony Mattessich
Eerdere bekende functies van Antony Mattessich
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| OCULAR THERAPEUTIX, INC. | Directeur/Bestuurslid | 01-06-2017 | 15-04-2024 |
| Algemeen Directeur | 01-08-2017 | 15-04-2024 | |
| President | 26-07-2017 | 15-04-2024 | |
Mundipharma International Ltd.
 Mundipharma International Ltd. Pharmaceuticals: MajorHealth Technology Mundipharma International Ltd. develops and produces pharmaceutical products. It offers analgesics, oncology, respiratory, gastrointestinal, and cardiovascular drugs. The company was founded in 1952 and is headquartered in Cambridge, the United Kingdom. | Directeur/Bestuurslid | 01-08-2017 | 18-12-2017 |
| Algemeen Directeur | 01-08-2017 | 18-12-2017 | |
| Corporate Officer/Principal | 01-01-2009 | 01-08-2017 | |
| President | 01-08-2017 | 18-12-2017 | |
Napp Pharmaceutical Holdings Ltd.
 Napp Pharmaceutical Holdings Ltd. Pharmaceuticals: MajorHealth Technology Napp Pharmaceutical Holdings Ltd. develops and provides medicines to patients. It offers prescription products for respiratory diseases such as asthma, inflammatory conditions, Crohn's disease, ulcerative colitis, ankylosing spondylitis, rheumatoid arthritis and psoriasis, as well as pain management, blood cancers, and cardiovascular conditions. The company was founded on December 19, 1997 and is headquartered in Cambridge, the United Kingdom. | Directeur/Bestuurslid | 01-01-2005 | 01-05-2011 |
| Algemeen Directeur | 01-01-2005 | 01-05-2011 | |
| NOVARTIS AG | Corporate Officer/Principal | 01-01-2003 | 01-01-2005 |
| BRISTOL-MYERS SQUIBB COMPANY | Directeur/Bestuurslid | - | - |
Opleiding van Antony Mattessich
| The Trustees of Columbia University in The City of New York | Graduate Degree |
| University of California, Berkeley | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
| Verenigd Koninkrijk | 3 |
| Zwitserland | 2 |
Operationeel
| Director/Board Member | 5 |
| Chief Executive Officer | 3 |
| Corporate Officer/Principal | 2 |
Sectoraal
| Health Technology | 7 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| OCULAR THERAPEUTIX, INC. | Health Technology |
| NOVARTIS AG | Health Technology |
| AURA BIOSCIENCES, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Napp Pharmaceutical Holdings Ltd.
Napp Pharmaceutical Holdings Ltd. Pharmaceuticals: MajorHealth Technology Napp Pharmaceutical Holdings Ltd. develops and provides medicines to patients. It offers prescription products for respiratory diseases such as asthma, inflammatory conditions, Crohn's disease, ulcerative colitis, ankylosing spondylitis, rheumatoid arthritis and psoriasis, as well as pain management, blood cancers, and cardiovascular conditions. The company was founded on December 19, 1997 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Mundipharma International Ltd.
Mundipharma International Ltd. Pharmaceuticals: MajorHealth Technology Mundipharma International Ltd. develops and produces pharmaceutical products. It offers analgesics, oncology, respiratory, gastrointestinal, and cardiovascular drugs. The company was founded in 1952 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Beurs
- Insiders
- Antony Mattessich
- Ervaring
